


Ask a doctor about a prescription for REVATIO 20 mg FILM-COATED TABLETS
Package Leaflet: Information for the Patient
Revatio 20mg Film-Coated Tablets
sildenafil
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the Package Leaflet
Revatio contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 inhibitors (PDE5).
Revatio reduces the blood pressure in the lungs by dilating the blood vessels in the lungs.
Revatio is used to treat high blood pressure in the blood vessels of the lungs (pulmonary arterial hypertension) in adults and children and adolescents from 1 to 17 years.
Do not take Revatio
Warnings and precautions
Consult your doctor or pharmacist before starting to take Revatio if
When PDE5 inhibitors, including sildenafil, are used to treat erectile dysfunction (ED), the following visual adverse effects have been reported with an unknown frequency: decreased or loss of vision, temporary or permanent, of one or both eyes. If you experience a reduction or loss of vision, stop taking Revatio and inform your doctor immediately(see also section 4).
Prolonged and sometimes painful erections have been reported in men taking sildenafil. If you have an erection that lasts for more than 4 hours, stop taking Revatio and consult your doctor immediately(see also section 4).
Special precautions in patients with kidney or liver problems
You should inform your doctor if you have kidney or liver problems, as a dose adjustment may be necessary.
Children
Revatio should not be given to children under 1 year of age.
Taking Revatio with other medicines
Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.
Taking Revatio with food and drinks
Do not take grapefruit juice when being treated with Revatio.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Revatio should not be used during pregnancy unless absolutely necessary.
Revatio should not be given to women of childbearing potential unless adequate contraceptive methods are used.
Revatio passes into breast milk at very low levels and is not expected to harm your baby.
Driving and using machines
Revatio may cause dizziness and affect vision. You should know how you react to this medicine before driving or using machines.
Revatio contains lactose
Before taking this medicine, consult your doctor if you have been told that you have an intolerance to some sugars.
Revatio contains sodium
Revatio 20 mg film-coated tablets contain less than 1 mmol of sodium (23 mg) per tablet; this is, essentially, “sodium-free”.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
For adults, the recommended dose is 20 mg three times a day (taken at intervals of 6 to 8 hours) taken with or without food.
Use in children and adolescents
For children and adolescents from 1 to 17 years, the recommended dose is 10 mg three times a day for children and adolescents ≤ 20 kg or 20 mg three times a day in children and adolescents > 20 kg, administered with or without food. In children, doses higher than those recommended should not be used. This medicine should only be used for cases where 20 mg three times a day is to be administered. For administration in patients ≤ 20 kg and in other younger patients who cannot swallow tablets, other pharmaceutical forms more suitable for their age and weight can be used.
If you take more Revatio than you should
Do not take more medicine than your doctor has told you.
If you have taken more medicine than you should, talk to your doctor immediately.
Taking more Revatio than you should can increase the risk of known side effects.
If you forget to take Revatio
If you have forgotten to take Revatio, take the dose as soon as you remember and then continue to take your medicine at the usual times. Do not take a double dose to make up for forgotten doses.
If you stop taking Revatio
Sudden interruption of treatment with Revatio may lead to worsening of your symptoms. Do not stop taking Revatio unless your doctor tells you to. Your doctor will tell you how to reduce the dose over a few days before stopping completely.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you experience any of the following side effects, stop taking Revatio and inform your doctor immediately (see also section 2):
Adults
The following side effects have been reported very frequently (may affect more than 1 in 10 people): headache or facial flushing, indigestion, diarrhea, and pain in arms and legs.
The following side effects have been reported frequently (may affect up to 1 in 10 people): infection under the skin, flu-like symptoms, inflammation of the nasal passages, reduction in the number of red blood cells (anemia), fluid retention, difficulty sleeping, anxiety, migraine, tremor, tingling sensation, burning sensation, reduced sense of touch, bleeding in the back of the eye, changes in vision, blurred vision, and sensitivity to light, effects on color perception, eye irritation, red eyes, dizziness, bronchitis, nosebleeds, runny nose, cough, stuffy nose, stomach inflammation, gastroenteritis, heartburn, hemorrhoids, abdominal distension, dry mouth, hair loss, skin flushing, night sweats, muscle pain, back pain, and increased body temperature.
The following side effects have been reported infrequently (may affect up to 1 in 100 people): reduced visual acuity, double vision, abnormal sensation in the eye, penile bleeding, presence of blood in the semen and/or urine, and gynecomastia.
The following have also been reported with an unknown frequency (frequency cannot be estimated from the available data): skin rash, sudden decrease or loss of hearing, and decreased blood pressure.
Children and adolescents
The following serious side effects have been reported frequently (may affect up to 1 in 10 patients): pneumonia, right heart failure, cardiogenic shock, high blood pressure in the lungs, chest pain, dizziness, respiratory infections, bronchitis, viral gastroenteritis, urinary tract infections, and tooth abscesses.
The following serious side effects have been reported infrequently (may affect up to 1 in 100 patients): allergic reaction (such as skin rash, facial swelling, lip and tongue swelling, sneezing, difficulty breathing or swallowing), seizures, irregular heartbeat, hearing disorders, shortness of breath, gastrointestinal inflammation, and sneezing due to airway disorders.
The following side effects have been reported very frequently (may affect more than 1 in 10 people): headache, vomiting, sore throat, fever, diarrhea, flu, and nosebleeds.
The following side effects have been reported frequently (may affect up to 1 in 10 patients): nausea, increased erections, pneumonia, and runny nose.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Medicines Vigilance System for Human Use: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of the month shown.
Do not store above 30°C. Store in the original package to protect from moisture.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Revatio
Core of the tablet: microcrystalline cellulose, calcium phosphate dibasic (anhydrous), sodium croscarmellose (see section 2 “Revatio contains sodium”), magnesium stearate.
Coating: hypromellose, titanium dioxide (E171), lactose monohydrate (see section 2 “Revatio contains lactose”), glycerol triacetate.
Appearance of Revatio and contents of the pack
Revatio film-coated tablets are white and round. The tablets are marked with “VLE” on one side and “RVT 20” on the other. The tablets are available in blisters containing 90 tablets, single-dose blisters containing 90 x 1 tablets, and blisters containing 300 tablets. Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder:
Upjohn EESV, Rivium Westlaan 142, 2909 LD Capelle aan den Ijssel, Netherlands
Manufacturer:
Fareva Amboise, Zone Industrielle, 29 route des Industries, 37530 Pocé-sur-Cisse, France.
Mylan Hungary Kft., Mylan utca 1, Komárom, 2900, Hungary.
You can request more information about this medicine from the local representative of the marketing authorization holder:
Spain
Viatris Pharmaceuticals, S.L.U.
Tel: +34 900 102 712
Date of last revision of this leaflet:
Other sources of information
Detailed information on this medicine is available on the European Medicines Agency website: http://www.ema.europa.eu. There are also links to other websites on rare diseases and orphan medicines.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for REVATIO 20 mg FILM-COATED TABLETS – subject to medical assessment and local rules.